FilingReader Intelligence
Tiantan Bio revenue rises 9% but profit falls 13%
August 6, 2025 at 05:10 PM UTC•By FilingReader AI
Beijing Tiantan Biological Products posted a 9.47% revenue increase to 311 million yuan in the first half of 2025, but net profit fell 12.88% to 63.3 million yuan.
Earnings per share dropped 12.88% to 0.32 yuan, highlighting the company's profitability challenges despite top-line growth.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600161•Shanghai Stock Exchange
Pharmaceuticals
News Alerts
Get instant email alerts when Beijing Tiantan Biological Products Corp publishes news
Free account required • Unsubscribe anytime